Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Theranostics 2012; 2(3):331-332. doi:10.7150/thno.4288 This issue Cite

Editorial

Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?

Hossein Jadvar✉

Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California

✉ Corresponding author: Hossein Jadvar, MD, PhD, MPH, MBA, Associate Professor of Radiology and Biomedical Engineering, Vice Chair of Research, Keck School of Medicine of USC, University of Southern California, 2250 Alcazar Street, CSC 102, Los Angele More

Citation:
Jadvar H. Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?. Theranostics 2012; 2(3):331-332. doi:10.7150/thno.4288. https://www.thno.org/v02p0331.htm
Other styles

File import instruction

Abstract

Positron emission tompography with radiolabeled (with 11C- or 18F-) choline has received much attention, particularly in Europe and Japan, over the past several years. While monitoring cellular membrane lipogenesis with radiolabeled choline is nonspecific for cancer, the malignancy-induced increased demand for cellular membrane synthesis can be a useful feature for imaging-based diagnosis and treatment evaluation. Many choline PET(/CT) studies have focused on prostate cancer given that 18F-flurodeoxyglucose appears to be primarily useful in progressive metastatic disease and is overall limited in the initial staging of disease or for evaluation of men with biochemical recurrence. The current evidence suggests that choline PET(/CT), particularly the 18F- label, may become routinely available, initially in many European countries, for the clinical imaging evaluation of men with prostate cancer.

Keywords: Prostate, Cancer, PET, Choline

Citation styles

APA
Jadvar, H. (2012). Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?. Theranostics, 2(3), 331-332. https://doi.org/10.7150/thno.4288.

ACS
Jadvar, H. Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?. Theranostics 2012, 2 (3), 331-332. DOI: 10.7150/thno.4288.

NLM
Jadvar H. Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?. Theranostics 2012; 2(3):331-332. doi:10.7150/thno.4288. https://www.thno.org/v02p0331.htm

CSE
Jadvar H. 2012. Can Choline PET Tackle the Challenge of Imaging Prostate Cancer?. Theranostics. 2(3):331-332.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use